“…Attempts have been made to clarify this hyperresponsiveness of arteriosclerotic vessels by experiments in vitro, but the results differed greatly depending on species and experimental conditions (Henry & Yokoyama, 1980;Godfraind & Miller, 1983;Kawachi et al, 1984;j / Ginsburg et al, 1984;Harrison et al, 1987). The defective endothelium-derived relaxing factor (EDRF) release in atherosclerotic vessels (Freiman et al, 1986;Jayakody et al, 1987a; (EDCF) or endothelin (Yanagisawa et al, 1988) as is found in hypertension or in regenerating endothelium (Luescher & Vanhoutte, 1986;Vanhoutte, 1987;Shimokawa et al, 1987 (Hof et al, 1987), for this purpose. The calcium after (continuous line) antagonist shifted the dose-response curves to NA cg 1. n = 6 for each and Phen (but not AII) more effectively to the right in atherosclerotic animals so that the pressor In summary, our experiments support the view that pressor effects of several vasoconstrictor agents are enhanced in atherosclerotic animals.…”